NCT02157636View on ClinicalTrials.gov

A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 15, 2014

Primary Completion Date

November 8, 2016

Study Completion Date

November 8, 2016

Conditions
Multiple Myeloma
Interventions
DRUG

CPI-0610

Sponsors
All Listed Sponsors
collaborator

The Leukemia and Lymphoma Society

OTHER

lead

Constellation Pharmaceuticals

INDUSTRY

NCT02157636 - A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma | Biotech Hunter | Biotech Hunter